Wednesday, March 18, 2026

Tag: biopharmaceuticals

Samsung Biologics Expands Global Reach: 280 Million USD Acquisition of US Bio-Manufacturing Facility

Samsung Biologics acquires a U.S. biopharmaceutical facility, enhancing its global CDMO capabilities and ensuring stable supply chains.